Home600664 • SHA
add
Harbin Pharmaceutical Group Co., Ltd.
Nakaraang pagsara
¥3.64
Sakop ng taon
¥2.41 - ¥4.13
Market cap
9.49B CNY
Average na Volume
35.52M
P/E ratio
16.19
Dividend yield
-
Primary exchange
SHA
Mga balita tungkol sa merkado
.INX
0.017%
1.52%
Mga Financial
Income Statement
Kita
Net na kita
(CNY) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 4.00B | 6.05% |
Gastos sa pagpapatakbo | 977.13M | 23.80% |
Net na kita | 166.64M | 175.81% |
Net profit margin | 4.17 | 160.62% |
Kita sa bawat share | — | — |
EBITDA | 274.38M | 50.36% |
Aktuwal na % ng binabayarang buwis | 22.99% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(CNY) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 3.18B | 22.51% |
Kabuuang asset | 14.24B | 3.68% |
Kabuuang sagutin | 8.48B | -0.98% |
Kabuuang equity | 5.76B | — |
Natitirang share | 2.52B | — |
Presyo para makapag-book | 1.82 | — |
Return on assets | 3.80% | — |
Return on capital | 7.00% | — |
Cash Flow
Net change in cash
(CNY) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 166.64M | 175.81% |
Cash mula sa mga operasyon | 344.42M | -1.27% |
Cash mula sa pag-invest | -15.62M | -70.10% |
Cash mula sa financing | 15.19M | 115.53% |
Net change in cash | 344.23M | 40.80% |
Malayang cash flow | 377.94M | 6.99% |
Tungkol
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Itinatag
1988
Website
Mga Empleyado
9,853